“In sickness and in health”: how individual immune response variability in health may influence how we respond to illness and therapy.
Thomas Fuller once said: "Health is not valued till sickness comes." Well, that may not be true anymore. It turns out that the key to successful disease management strategies may lie with a better understanding of individual immune response variabilities...
Identifying Signaling Pathways and Biomarkers in Autoimmune Diseases
As efforts in developing targeted therapies for autoimmune disease are rapidly advancing in basic research, scientists aim to validate immunology-relevant signaling pathways and uncover new intracellular molecules as potential drug targets. The NanoString® nCounter® Autoimmune Profiling and Immunology panels are...